Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 September 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 189 pages)

 

Export 9 results:
[ Author(Desc)] Title Type Year
Filters: Author is Morgan, C. L.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
C. L. Morgan, Inzucchi, S. E., Puelles, J., Jenkins-Jones, S., and Currie, C. J., Impact of treatment with pioglitazone on stroke outcomes: A real-world database analysis, Diabetes Obes Metab, vol. 20, pp. 2140-2147, 2018.
C. L. Morgan, Qiao, Q., Grandy, S., Johnsson, K., Jenkins-Jones, S., Holden, S., and Currie, C. J., Glucose Control and Weight Change Associated with Treatment with Exenatide Compared with Basal Insulin: A Retrospective Study, Diabetes Ther, vol. 9, pp. 269-283, 2018.
C. L. Morgan, Mukherjee, J., Jenkins-Jones, S., Holden, S. E., and Currie, C. J., Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational study, Diabetes Obes Metab, vol. 16, pp. 957-62, 2014.
C. L. Morgan, Mukherjee, J., Jenkins-Jones, S., Holden, S. E., and Currie, C. J., Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortality, Diabetes Obes Metab, vol. 16, pp. 977-83, 2014.
C. L. Morgan, Puelles, J., Poole, C. D., and Currie, C. J., The effect of withdrawal of rosiglitazone on treatment pathways, diabetes control and patient outcomes: a retrospective cohort study, J Diabetes Complications, vol. 28, pp. 360-4, 2014.
C. L. Morgan, Jenkins-Jones, S., Currie, C. J., and Rees, D. A., Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study, J Clin Endocrinol Metab, vol. 97, pp. 3251-60, 2012.
C. L. Morgan, Poole, C. D., Evans, M., Barnett, A. H., Jenkins-Jones, S., and Currie, C. J., What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes, J Clin Endocrinol Metab, vol. 97, pp. 4605-12, 2012.
C. L. Morgan, Owens, D. R., Aubonnet, P., Carr, E. S., Jenkins-Jones, S., Poole, C. D., and Currie, C. J., Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study, BMJ Open, vol. 3, p. e004025, 2013.
C. L. Morgan, Jenkins-Jones, S., Currie, C., and Baxter, G., Outcomes Associated with Treatment of Chronic Pain with Tapentadol Compared with Morphine and Oxycodone: A UK Primary Care Observational Study, Adv Ther, 2019.
[Page last reviewed 6 September 2019]